Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1231

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 1231
---
 Expected Dividends 
     0%
  
    Discount Rate (Monte-Carlo model only) 
     12%
  
    Expected Term (years) 
     0.56 – 9.88 

    F-14

The following table sets forth the Level 3 liability
at June 30, 2025, which is recorded on the consolidated balance sheet at fair value on a recurring basis. As required, this liability
is classified based on the lowest level of input that is significant to the fair value measurement.

The roll forward of contingent consideration liability
is as follows:

    Schedule of fair value measurement on recurring basis 

    Fair Value Measurements at Reporting Date Using

    Quoted Prices in  Active Markets for Identical Assets Inputs 
    Significant Other  Observable Inputs 
    Significant Other Unobservable Inputs

    (Level 1) 
    (Level 2) 
    (Level 3)

    The roll forward of the contingent consideration liability is as follows: 

    Balance June 30, 2024 
     —  
     —  
    $12,310,000 
  
    Fair value adjustment 
     —  
     —  
     (11,680,000)
  
    Contingent Consideration Liability at June 30, 2025 
     —  
     —  
    $630,000 

NOTE 4 - PROPERTY AND EQUIPMENT

Property and equipment consisted of the following at
June 30, 2025 and 2024:

    Schedule of Property and equipment 

    Useful Life 
    June 30, 2025 
    June 30, 2024
  
    Lab equipment and instruments 
     4-7  
    $639,998  
    $639,998 
  
    Leasehold improvements 
     10  
     224,629  
     224,629 
  
    Furniture, fixtures, and equipment 
     4-7  
     205,396  
     195,834 
  
    Total 
        
     1,070,023  
     1,060,461 
  
    Less accumulated depreciation 
        
     (702,180) 
     (578,340)
  
    Net Property and Equipment 
        
    $367,843  
    $482,121 

Depreciation expense amounted
to $